We are live on
!
Find out more
AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
10.36%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.66B
AUM Growth
+$11.4M
(+0.43%)
Cap. Flow
-$365M
Cap. Flow
% of AUM
-13.71%
Top 10 Holdings %
Top 10 Hldgs %
23.28%
Holding
276
New
116
Increased
46
Reduced
39
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$73.4M |
| 2 |
WCN
Waste Connections
WCN
|
+$43.4M |
| 3 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$39.5M |
| 4 |
AET
Aetna Inc
AET
|
+$38.9M |
| 5 |
Diamondback Energy
FANG
|
+$33.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$115M |
| 2 |
Puma Biotechnology
PBYI
|
+$65.5M |
| 3 |
Prudential Financial
PRU
|
+$64M |
| 4 |
Host Hotels & Resorts
HST
|
+$61M |
| 5 |
Amazon
AMZN
|
+$47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.44% |
| 2 | Technology | 12.23% |
| 3 | Energy | 11.54% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ecovyst
ECVT
$1.32B
| $8.9M | 0.33% |
541,220
+17,476
| +3% | +$286K |
|
77
Molina Healthcare
MOH
$10.4B
| $8.9M | 0.33% |
116,022
+65,392
| +129% | +$4.72M |
|
|
TMX
78
DELISTED
Terminix Global Holdings, Inc.
TMX
| $8.72M | 0.33% |
+253,853
| New | +$8.18M |
|
79
Teva Pharmaceuticals
TEVA
$40.4B
| $8.52M | 0.32% |
+449,390
| New | +$6.76M |
|
80
Cognizant
CTSH
$26.5B
| $8.36M | 0.31% |
+117,639
| New | +$8.6M |
|
|
MRNS
81
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.26M | 0.31% |
+253,214
| New | +$6.82M |
|
82
American Tower
AMT
$83.5B
| $8.22M | 0.31% |
+57,594
| New | +$8.22M |
|
83
Oracle
ORCL
$339B
| $8.2M | 0.31% |
+173,490
| New | +$8.51M |
|
|
LOGM
84
DELISTED
LogMein, Inc.
LOGM
| $8.08M | 0.3% |
+70,552
| New | +$8.29M |
|
85
Aptiv
APTV
$12.3B
| $8.06M | 0.3% |
95,028
+70,028
| +280% | +$6.67M |
|
|
EDR
86
DELISTED
Education Realty Trust Inc
EDR
| $8.04M | 0.3% |
230,349
+53,012
| +30% | +$1.91M |
|
87
Mondelez International
MDLZ
$83.4B
| $7.92M | 0.3% |
+185,064
| New | +$7.77M |
|
|
EVHC
88
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $7.85M | 0.29% |
+227,101
| New | +$7.94M |
|
|
ALDR
89
DELISTED
Alder Biopharmaceuticals
ALDR
| $7.72M | 0.29% |
674,494
+170,319
| +34% | +$1.9M |
|
|
CONE
90
DELISTED
CyrusOne Inc Common Stock
CONE
| $7.72M | 0.29% |
+129,689
| New | +$7.87M |
|
91
Capital One
COF
$128B
| $7.62M | 0.29% |
+76,485
| New | +$6.98M |
|
92
CoreCivic
CXW
$2.94B
| $7.53M | 0.28% |
+334,740
| New | +$8.04M |
|
93
SBA Communications
SBAC
$19.8B
| $7.45M | 0.28% |
+45,615
| New | +$7.25M |
|
94
Ametek
AME
$53.9B
| $6.83M | 0.26% |
94,173
-121,104
| -56% | -$8.44M |
|
95
MSC Industrial Direct
MSM
$6.76B
| $6.5M | 0.24% |
+67,201
| New | +$5.62M |
|
96
Morgan Stanley
MS
$319B
| $6.26M | 0.24% |
+119,272
| New | +$6.03M |
|
|
LJPC
97
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $6.08M | 0.23% |
+189,041
| New | +$6.18M |
|
98
Netflix
NFLX
$307B
| $6.03M | 0.23% |
313,920
+213,040
| +211% | +$4.1M |
|
99
Huntsman Corp
HUN
$2.1B
| $5.89M | 0.22% |
+177,063
| New | +$5.42M |
|
|
CALA
100
DELISTED
Calithera Biosciences, Inc
CALA
| $5.79M | 0.22% |
34,690
+1,780
| +5% | +$456K |
|
Similar funds
MWAC
TP
PC
RW
TBC
BWCA
AC
GCM
Ascend Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Ascend Capital held 276 positions worth $2.66B, up 0.43% from $2.65B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ascend Capital withdrew a net $365M in Q4 2017, closing 64 positions and reducing 39 holdings. Its most notable exit was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $115M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Energy.
Against the trend, Ascend Capital opened a new position in CVS Health worth $73.2M.
- Ascend Capital's largest Q4 2017 buy was CVS Health: 1,009,152 shares worth $73.2M.
- Ascend Capital added most to Waste Connections in Q4 2017, an estimated $43.4M increase.
- Ascend Capital's biggest Q4 2017 reduction was Puma Biotechnology, cutting an estimated $65.5M.
- Ascend Capital fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q4 2017, selling an estimated $115M.
- Ascend Capital's ten largest holdings make up 23% of its $2.66B portfolio in Q4 2017.
- Ascend Capital opened 116 new positions and closed 64 in Q4 2017.
- Ascend Capital's portfolio value rose 0.43% quarter-over-quarter to $2.66B.
Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.